WHO guideline: the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health care settings

Injection practices worldwide and especially in low- and middle-income countries (LMICs) include multiple, avoidable unsafe practices that ultimately lead to the large-scale transmission of bloodborne viruses among patients, health care providers and the community at large.